Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2017.06.009
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2017
Authors
Publisher
Elsevier BV